Evidence map›Paper›PMID 20220088›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2010

Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells.

Carl E Allen, Liunan Li, Tricia L Peters, Hon-Chiu Eastwood Leung, Alexander Yu, Tsz-Kwong Man, Sivashankarappa Gurusiddappa, Michelle T Phillips, M John Hicks, Amos Gaikwad and 2 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 135 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
135citing papers in PubMed, 1 pooled it
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

135 citing papers in PubMed, 1 synthesis or guideline pooled it, 321 citations in OpenAlex.

  1. Merkel cell polyomavirus and Langerhans cell neoplasm.Cell communication and signaling : CCS · 2018
    Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Merkel cell polyomavirus DNA sequences in tissue from a patient with Histiocytosis.Journal of clinical and experimental hematopathology : JCEH · 2025
    Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

75 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Carl E AllenDepartment of Pediatrics, Texas Children's Cancer Center and Hematology Service, Baylor College of Medicine, Houston, TX 77030, USA. ceallen@txccc.org
Liunan Li
Tricia L Peters
Hon-Chiu Eastwood Leung
Alexander Yu
Tsz-Kwong Man
Sivashankarappa Gurusiddappa
Michelle T Phillips
M John Hicks
Amos Gaikwad
Miriam Merad
Kenneth L McClain
Children's Cancer Center · USBaylor College of Medicine · USDan L Duncan Comprehensive Cancer CenterIcahn School of Medicine at Mount Sinai · US

Funding

Tissue ResourceP50CA126752 · NCI · BAYLOR COLLEGE OF MEDICINE · PI MALCOLM K. BRENNER, HELEN E HESLOP · 2007 to 2026
$51.4M
Pediatric Oncology Research Training ProgramT32CA115303 · NCI · BAYLOR COLLEGE OF MEDICINE · PI POPLACK, DAVID G. · 2006 to 2010
$1.5M
Cytokine Expression in LCH and Therapeutic ResponseR21CA114981 · NCI · BAYLOR COLLEGE OF MEDICINE · PI MCCLAIN, KENNETH L · 2006 to 2007
$469k
NCI NIH HHS P50 CA126752NCI NIH HHS R21 CA114981NCI NIH HHS R21 CA 114981-01A2NCI NIH HHS T32 CA115303NCI NIH HHS T32 CA115303-03NIAID NIH HHS L40 AI076739
6 · The paper itself

Abstract

Langerhans cell histiocytosis (LCH) is a rare disease characterized by heterogeneous lesions containing CD207(+) Langerhans cells (LCs) and lymphocytes that can arise in almost any tissue and cause significant morbidity and mortality. After decades of research, the cause of LCH remains speculative. A prevailing model suggests that LCH arises from malignant transformation and metastasis of epidermal LCs. In this study, CD207(+) cells and CD3(+) T cells were isolated from LCH lesions to determine cell-specific gene expression. Compared with control epidermal CD207(+) cells, the LCH CD207(+) cells yielded 2113 differentially expressed genes (false discovery rate < 0.01). Surprisingly, the expression of many genes previously associated with LCH, including cell-cycle regulators, proinflammatory cytokines, and chemokines, were not significantly different from control LCs in our study. However, several novel genes whose products activate and recruit T cells to sites of inflammation, including SPP1 (osteopontin), were highly overexpressed in LCH CD207(+) cells. Furthermore, several genes associated with immature myeloid dendritic cells were overexpressed in LCH CD207(+) cells. Compared with the peripheral CD3(+) cells from LCH patients, the LCH lesion CD3(+) cells yielded only 162 differentially regulated genes (false discovery rate < 0.01), and the expression profile of the LCH lesion CD3(+) cells was consistent with an activated regulatory T cell phenotype with increased expression of FOXP3, CTLA4, and SPP1. Results from this study support a model of LCH pathogenesis in which lesions do not arise from epidermal LCs but from accumulation of bone marrow-derived immature myeloid dendritic cells that recruit activated lymphocytes.

Indexed as

Epidermal CellsGene Expression ProfilingAdolescentAntigens, CDBiomarkersCD3 ComplexChildChild, PreschoolEpidermisHistiocytosis, Langerhans-CellHumansInfantLangerhans CellsLectins, C-TypeMannose-Binding LectinsOligonucleotide Array Sequence AnalysisAntigens, CDBiomarkersCD207 protein, humanCD3 ComplexLectins, C-TypeMannose-Binding Lectins

Identifiers

PMID20220088
PMCPMC3142675
OpenAlexW2168827093

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.